NEW YORK, Nov. 28, 2016 /PRNewswire/ -- The litigation involving the alleged link between ovarian cancer and Johnson & Johnson's Baby Powder and Shower-to-Shower talc-based powders continues to move forward in state and federal jurisdictions around the country. Court records indicate that a coordinated proceeding was recently established in California Superior Court, Los Angeles County, for that state's talcum powder docket. The litigation was scheduled to convene a hearing on November 22nd, at which time document production, in extremis depositions, and other matters pertaining to discovery were to be addressed. (Johnson & Johnson Talcum Powder Cases, No. JCCP4872)
"Our Firm is investigating a number of talcum powder ovarian cancer claims involving Johnson & Johnson. The California litigation is just one of several centralized proceedings we are monitoring for developments that may impact our clients' cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to victims of ovarian cancer allegedly related to the use of Johnson & Johnson's talc-based powders. Nationwide Talcum Powder Litigation Court records indicate that more than 2,000 talcum powder ovarian cancer lawsuits have been filed against Johnson & Johnson in courts around the U.S. Plaintiffs allege that the regular and repeated application of Baby Powder or Shower-to-Shower to the female genitals can allow talc particles to enter the vagina and make their way to the ovaries. Over time, this can result in inflammation that may promote the growth of ovarian cancer cells. Plaintiffs further allege that Johnson & Johnson has been aware of studies pointing to such a link for decades, yet neglected to provide any warnings to consumers in order to protect sales of Baby and Shower-to-Shower.